Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | July 16, 2020 | July 28, 2020 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 02, 2023 | June 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,847 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 17,847 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
CASTLE BIOSCIENCES INC
Report date July 16, 2020 · Filed July 28, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy trust | 21,723 |
Last balance in matching sequence
After 2020-07-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-07-16 · Sale · Disposed 1,228 · Balance 23,495 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 2 · 2020-07-16 · Sale · Disposed 1,763 · Balance 21,732 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 3 · 2020-07-16 · Sale · Disposed 9 · Balance 21,723 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
VERACYTE, INC.
Report date June 02, 2023 · Filed June 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,377 |
Reported balance
After 2023-06-02 transaction · row 1
1 source rowRow 1 · 2023-06-02 · Tax withholding · Disposed 1,304 · Balance 41,377 F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectThe Bonnie H. Anderson Living Trust | 134,800 |
Reported balance
Holding disclosure · report date 2023-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 134,800 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2019 Filed May 13, 2019 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,660 | $22.77 | $128,903.10 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,632 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $22.34 to $23.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $25.39 | $203,084.00 |
DisclosureSEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,292 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.98 to $25.68. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000034 · wf-form4_155501741939389.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 20:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | GiftCommon Stock | 7,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,292 Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $19.97 | $159,745.60 |
DisclosureSEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,592 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $19.79 to $20.23. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000032 · wf-form4_155251071460809.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| March 02, 2019 Filed Mar 4, 2019 23:57 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000020 · wf-form4_155174382498976.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,592 F1 · shares: The reporting person is reporting the withholding of 3,949 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 7,500 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $20.21 | $0.00 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2029-02-27 F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,541 F4 · kind: Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter, based on continuing service on each vesting date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,500 Underlying: Common Stock · 20,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,700 | $21.58 | $101,405.79 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $21.54 to $21.63. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 15,300 | $20.74 | $317,323.53 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,241 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $20.48 to $21.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $2.68 | $53,600.00 |
DisclosureSEC source: 0001384101-19-000016 · wf-form4_155139072059287.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000006 · wf-form4_155001051878761.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $18.17 | $145,364.00 |
DisclosureSEC source: 0001384101-19-000006 · wf-form4_155001051878761.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $17.89 to $18.57. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000006 · wf-form4_155001051878761.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · derivative · entry 8 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,728 | $16.14 | $27,893.03 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $16.01 to $16.49. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,272 | $15.52 | $97,355.24 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,269 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $15.00 to $15.99. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 17,500 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 17,500 | $15.12 | $264,649.00 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $15.00 to $15.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 22:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 17,500 | $2.68 | $46,900.00 |
DisclosureSEC source: 0001384101-19-000004 · wf-form4_154724545069552.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · derivative · entry 8 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,526 Underlying: Common Stock · 24,000 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 24,000 | $2.36 | $56,640.00 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,305 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 1,305 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,695 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,695 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $12.13 | $97,076.80 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $11.76 to $12.50. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,305 | $2.68 | $3,497.40 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 01:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,695 | $2.36 | $15,800.20 |
DisclosureSEC source: 0001384101-18-000084 · wf-form4_154457759967791.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 23,305 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000082 · wf-form4_154215102138741.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,695 Underlying: Common Stock · 23,305 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,691 | $13.82 | $23,365.56 |
DisclosureSEC source: 0001384101-18-000082 · wf-form4_154215102138741.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $13.70 to $14.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 21,614 | $13.39 | $289,420.11 |
DisclosureSEC source: 0001384101-18-000082 · wf-form4_154215102138741.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,232 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $12.70 to $13.69. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 23,305 | $2.36 | $54,999.80 |
DisclosureSEC source: 0001384101-18-000082 · wf-form4_154215102138741.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000072 · wf-form4_153548921385828.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,305 Underlying: Common Stock · 6,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F3 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,000 | $12.00 | $71,971.20 |
DisclosureSEC source: 0001384101-18-000072 · wf-form4_153548921385828.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $11.78 to $12.24. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,000 | $2.68 | $16,080.00 |
DisclosureSEC source: 0001384101-18-000072 · wf-form4_153548921385828.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 20:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 14,950 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000068 · wf-form4_153332670271016.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,305 Underlying: Common Stock · 14,950 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 20:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 14,950 | $11.50 | $171,925.00 |
DisclosureSEC source: 0001384101-18-000068 · wf-form4_153332670271016.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 20:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 14,950 | $2.68 | $40,066.00 |
DisclosureSEC source: 0001384101-18-000068 · wf-form4_153332670271016.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 50 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000066 · wf-form4_153264054818805.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,255 Underlying: Common Stock · 50 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 50 | $11.50 | $575.00 |
DisclosureSEC source: 0001384101-18-000066 · wf-form4_153264054818805.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 50 | $2.68 | $134.00 |
DisclosureSEC source: 0001384101-18-000066 · wf-form4_153264054818805.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 22:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000062 · wf-form4_153247033713303.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,305 Underlying: Common Stock · 6,000 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 22:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,000 | $10.20 | $61,174.80 |
DisclosureSEC source: 0001384101-18-000062 · wf-form4_153247033713303.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.96 to $10.43. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 22:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,000 | $2.68 | $16,080.00 |
DisclosureSEC source: 0001384101-18-000062 · wf-form4_153247033713303.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 914 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000054 · wf-form4_153013433764259.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,305 Underlying: Common Stock · 914 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.